Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma
Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma
Languages of Item:
English
Abstract:
Empty abstract
Publication year:
2009
Authors:
Dimopoulos, MA Chen, C Spencer, A Niesvizky, R Attal, M Stadtmauer, EA Petrucci, MT Yu, Z Olesnyckyj, M Zeldis, JB others
